Objectives

After participating in this educational activity, attendees should be able to:
1|Describe the purpose and key requirements of the Drug Supply Chain Security Act (DSCSA) as they apply to pharmacy practice
2|Identify characteristics and situations that may indicate a suspect or illegitimate drug product within the medication supply chain
3|Explain appropriate pharmacist actions for verification, documentation, quarantine, and escalation when a potential DSCSA concern is identified

Presenter(s): 
Madalyn Dankocsik, PharmD
PGY2 Health-System Pharmacy Administration and Leadership Resident
Baystate Medical Center

NameRoleFinancial Relationship DisclosuresDiscussion of
Unlabeled/Unapproved Uses of
Drugs/Devices in Presentation?
Madalyn Dankocsik, PharmDSpeakerNo relevant relationships with ineligible companies to discloseNo
Session date: 
11/09/2026 - 2:00pm to 3:00pm EST
Location: 
Hybrid - Baystate Medical Center & Webinar
759 Chestnut Street
Springfield, MA 01199
United States
  • 1.00 ACPE Contact Hours
  • 1.00 ACPE Technician contact hours
Please login or register to take this course.